[{"indications": "Indications\u00a0see Dose", "name": "TETRABENAZINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.9 Drugs used in parkinsonism and related disorders", "4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders", "TETRABENAZINE"], "cautions": "Cautions\u00a0avoid abrupt withdrawal; susceptibility to QT-interval\r\nprolongation (including concomitant use of drugs that prolong QT interval); interactions: Appendix 1 (tetrabenazine)Driving\u00a0May affect performance of\r\nskilled tasks (e.g. driving)", "side-effects": "Side-effects\u00a0dysphagia, nausea, vomiting, diarrhoea, constipation,\r\nhypotension, depression, anxiety, insomnia, confusion, drowsiness,\r\nparkinsonism; less commonly altered consciousness\r\nlevel, extrapyramidal disorders, hyperthermia; rarely neuroleptic malignant syndrome; very rarely rhabdomyolysis; also reported dry mouth, dyspepsia, bradycardia, disorientation,\r\nagitation, dizziness, amnesia, ataxia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/215692.htm", "doses": ["Movement disorders due to Huntington\u2019s chorea, hemiballismus,\r\nsenile chorea, and related neurological conditions, initially 25\u00a0mg\r\n3 times daily, increased by 25\u00a0mg every 3\u20134 days as tolerated to max.\r\n200\u00a0mg daily", "Lower initial doses may be necessary in elderly\r\npatients", "Moderate to severe tardive dyskinesia, initially 12.5\u00a0mg daily,\r\ngradually increased according to response"], "pregnancy": "Pregnancy\u00a0avoid unless essential\u2014toxicity in animal studies"}]